Neumora Therapeutics Reports Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder

Press/Media

Period	30 Jul 2023

Media coverage

Title	Neumora Therapeutics Reports Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder
Media name/outlet	Manufacturing Close-Up
Country/Territory	United States
Date	30/07/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=68TT-04M1-F06S-P42Y-00000-00
Persons	Sanjay Mathew